Zacks Investment Research cut shares of ASPEN PHARMACAR/ADR (OTCMKTS:APNHY) from a hold rating to a sell rating in a report released on Monday, Zacks.com reports.
According to Zacks, “Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa. “
Separately, ValuEngine upgraded ASPEN PHARMACAR/ADR from a sell rating to a hold rating in a report on Wednesday, October 2nd.
APNHY opened at $6.61 on Monday. The stock has a fifty day simple moving average of $5.86 and a two-hundred day simple moving average of $6.46. The company has a market cap of $3.01 billion, a price-to-earnings ratio of 5.29, a price-to-earnings-growth ratio of 0.96 and a beta of 1.10. ASPEN PHARMACAR/ADR has a 12-month low of $4.14 and a 12-month high of $11.79.
About ASPEN PHARMACAR/ADR
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. The company offers various oral solid dose, liquids, semi-solids, steriles, biogicals, active pharmaceutical ingredients, and infant nutritional products.
Read More: Earnings Per Share
Get a free copy of the Zacks research report on ASPEN PHARMACAR/ADR (APNHY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for ASPEN PHARMACAR/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASPEN PHARMACAR/ADR and related companies with MarketBeat.com's FREE daily email newsletter.